Athrappully by NAVEEN
Artist
The US Food and Drug Administration should protect Americans in the United States, protect Americans, protect Americans from GLP-1 weight loss and diabetes drugs such as Ozempic and Mounjaro, and take a “decisive behavior” in 38 US lawyers’ union letters.
“My fellow lawyers and I are urging the FDA to protect consumers from an increasing threat from adultery or counterfeit version of this drug.
“From the prosecutor to the execution measures, the FDA has some important tools to help to end this illegal behavior. Many counterfeit drugs are shipped outside the country, so federal response is required. ”
Both letters, issued a day ago, said the demand for GLP-1 drugs such as Mounjaro, Zepbound, Ozempic and Wegovy said that the demand for GLP-1 drugs has soared. The high cost of this drug and lack of supply is that “criminals have created an opportunity to risk consumers in cash.”
Fake GLP-1 drugs have entered the US supply chain in countries such as China, Türkiye and India, lawyers said.
“This counterfeit may include contaminants, other unknown drugs or dangerous active ingredients. The scammers also re -wraped the injectable insulin and falsely sold them as Oz Pick. ”
Injecting counterfeit drugs, “It can cause serious side effects for consumers, and sometimes you may need hospitalization.
The letter raised the issue of selling the active ingredients of GLP-1 drugs directly to consumers online without prescription. This active ingredient is said to be at risk of contamination because it comes from unmodified sources.
Consumers use the ingredients to safely dissolve the active ingredients to formulate the drug without proper knowledge of dragging substances into the syringe and injecting substances into the body.
In addition, there are complex pharmacies that create GLP-1 drugs for themselves, and some are chosen as “cutting corners” to pursue profits, a letter said. Last year, ELI Lilly and Company, manufacturers of Mounjaro and Zepbound, said they confirmed complex drugs with “safety, sterilization and efficacy problems.”
“Some include bacteria, high impurities levels, different colors (pink, colorless) or FDA approval drugs of LILLY.
NOVO NORDISK, which manufactures Ozempic and Wegovy, filed a lawsuit for several pharmacies, weight loss clinics and medical spas in several US states.
The letter to the FDA said, “Before reaching an unfortunate consumer, we demanded cooperation with federal partners such as the Ministry of Land, Infrastructure and Transport to intercept the counterfeit GLP-1 drug.
The agency asked people to send a warning letter to the seller who supplied the active material.
The lawyer said, “The FDA should also strengthen the execution of complex pharmacies that can illegally participate in the market.” “FDA must work with the main pharmacy board so that the combined GLP-1 drug is produced in a safe and hygienic manner.”
Health risk and lack
There were many examples of fake GLP-1 drugs that cause health problems.
In October 2023, the Federal Federal Office for Austria’s health care safety said it received a report on some people who had to be treated at the hospital after using the forgery Ozempic. The patient has seizures and hypoglycemia and occurs when the blood sugar level is very low.
The British authorities have announced warnings about fake Ozvik in the same month. Side effects included hypoglycemic shock and coma.
In December 2023, the FDA announced the seizure of thousands of counterfeit Ozempic found in the “Legal US Pharmaceutical Supply Pass.”
On February 21, the FDA announced that the tribe of three -glutide was resolved. These products have been lacking in terms of increase in demand since 2022.
“The FDA has confirmed that the product availability and manufacturing capacity specified with pharmaceutical manufacturers can meet current demand.
“Patients and prescribers can still see intermittent and limited local supply as they move the supply chain from manufacturers and distributors to local pharmacies.”
Novo Nordisk said that all capacity FDA approval Cebu Glutite (Wegovy and Ozempic) says that it continues to be shipped, meetings or expected US demand.
“The decision of the FDA is essentially illegal except for the exception of creating or selling a rust -out complex, a copy of Ozempic or Wegovy.”
Meanwhile, the actual GLP-1 drug can also cause health risks. Recent studies show that there was a higher risk of rare eye condition among individuals with type 2 diabetes using Semaglutide.
Non -aneurysms are called neuropathy when the anterior ischemia is caused by sending signals from the eye to the brain when the blood flows into the optic nerve. This can lead to a sudden loss of vision.
The authors of the research said, “Without known mechanisms of this association, clinical trials urge to assess concerns about the rare but potentially blind risk of Semaglutide.
